SCHEMBL5825249

SCHEMBL5825249

COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4cccc5ccccc45)cc3Cl)c2cc1OC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 9/20 0.64
KDR P35968 8/20 0.64
PDGFRA P16234 8/20 0.61
KIT P10721 4/20 0.61
PDGFRB P09619 1/20 0.55
AXL P30530 1/20 0.55
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
KMT2A Q03164 1/20 0.49
POLB P06746 1/20 0.49
ESRRA P11474 1/20 0.47
AURKA O14965 1/20 0.46
LCK P06239 1/20 0.46
CSF1R P07333 1/20 0.46
BRAF P15056 1/20 0.46
FLT1 P17948 1/20 0.46
FGFR2 P21802 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5824635 0.92 MET (0.68) METKDRPDGFRAKITPDGFRB
SCHEMBL1876485 0.92 MET (0.68) METKDRPDGFRAKITPDGFRB
SCHEMBL1880481 0.91 MET (0.66) METKDRPDGFRAKITPDGFRB
SCHEMBL1877307 0.90 MET (0.72) METKDRPDGFRAKITPDGFRB
SCHEMBL1876150 0.88 MET (0.81) METKDRPDGFRAKITPDGFRB
SCHEMBL1880671 0.88 MET (0.62) METKDRPDGFRAKITPDGFRB
SCHEMBL5825802 0.88 MET (0.69) METKDRPDGFRAKITPDGFRB
SCHEMBL1875102 0.86 KDR (0.70) METKDRPDGFRAKITPDGFRB
SCHEMBL1876860 0.85 MET (0.69) METKDRPDGFRAKITPDGFRB
SCHEMBL1877478 0.85 MET (0.69) METKDRPDGFRAKITPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135466-B2 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA MET 84/4885KDR 4/4885PDGFRA 1/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA MET 40/4885KDR 5/4885PDGFRA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.